Annual CAPEX
$7.39 B
+$4.41 B+147.62%
31 December 2023
Summary:
Eli Lilly and Company annual capital expenditures is currently $7.39 billion, with the most recent change of +$4.41 billion (+147.62%) on 31 December 2023. During the last 3 years, it has risen by +$5.36 billion (+264.30%). LLY annual CAPEX is now at all-time high.LLY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$4.17 B
+$2.77 B+197.32%
30 September 2024
Summary:
Eli Lilly and Company quarterly capital expenditures is currently $4.17 billion, with the most recent change of +$2.77 billion (+197.32%) on 30 September 2024. Over the past year, it has increased by +$169.60 million (+4.24%). LLY quarterly CAPEX is now at all-time high.LLY Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$8.31 B
+$169.60 M+2.08%
30 September 2024
Summary:
Eli Lilly and Company TTM capital expenditures is currently $8.31 billion, with the most recent change of +$169.60 million (+2.08%) on 30 September 2024. Over the past year, it has increased by +$1.93 billion (+30.22%). LLY TTM CAPEX is now at all-time high.LLY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +147.6% | +4.2% | +30.2% |
3 y3 years | +264.3% | +815.5% | +261.4% |
5 y5 years | +144.9% | +1122.8% | +403.3% |
LLY CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +273.6% | at high | +815.5% | at high | +319.9% |
5 y | 5 years | at high | +446.1% | at high | +1437.3% | at high | +578.6% |
alltime | all time | at high | +1918.0% | at high | >+9999.0% | at high | +4996.6% |
Eli Lilly And Company CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $4.17 B(+197.3%) | $8.31 B(+2.1%) |
June 2024 | - | $1.40 B(+29.6%) | $8.14 B(+7.5%) |
Mar 2024 | - | $1.08 B(-34.4%) | $7.57 B(+2.4%) |
Dec 2023 | $7.39 B(+147.6%) | $1.65 B(-58.7%) | $7.39 B(+15.9%) |
Sept 2023 | - | $4.00 B(+378.4%) | $6.38 B(+110.5%) |
June 2023 | - | $836.30 M(-7.4%) | $3.03 B(+0.8%) |
Mar 2023 | - | $903.50 M(+41.5%) | $3.01 B(+0.8%) |
Dec 2022 | $2.99 B(+50.9%) | $638.60 M(-2.1%) | $2.99 B(+4.9%) |
Sept 2022 | - | $652.10 M(-19.9%) | $2.85 B(+7.4%) |
June 2022 | - | $813.60 M(-7.7%) | $2.65 B(+11.9%) |
Mar 2022 | - | $881.00 M(+76.4%) | $2.37 B(+19.7%) |
Dec 2021 | $1.98 B(-2.5%) | $499.40 M(+9.6%) | $1.98 B(-13.9%) |
Sept 2021 | - | $455.60 M(-14.2%) | $2.30 B(+1.8%) |
June 2021 | - | $531.30 M(+8.0%) | $2.26 B(+0.4%) |
Mar 2021 | - | $492.10 M(-40.0%) | $2.25 B(+10.9%) |
Dec 2020 | $2.03 B(+49.9%) | $819.50 M(+97.4%) | $2.03 B(+32.1%) |
Sept 2020 | - | $415.10 M(-20.7%) | $1.54 B(+5.1%) |
June 2020 | - | $523.20 M(+92.8%) | $1.46 B(+19.4%) |
Mar 2020 | - | $271.30 M(-16.9%) | $1.22 B(-9.6%) |
Dec 2019 | $1.35 B(-55.2%) | $326.50 M(-4.3%) | $1.35 B(-18.0%) |
Sept 2019 | - | $341.10 M(+19.6%) | $1.65 B(+2.6%) |
June 2019 | - | $285.30 M(-28.8%) | $1.61 B(-49.4%) |
Mar 2019 | - | $400.60 M(-35.8%) | $3.18 B(+5.4%) |
Dec 2018 | $3.02 B(+39.5%) | $623.70 M(+108.0%) | $3.02 B(+4.5%) |
Sept 2018 | - | $299.80 M(-83.9%) | $2.89 B(-4.9%) |
June 2018 | - | $1.86 B(+685.7%) | $3.04 B(+117.0%) |
Mar 2018 | - | $236.50 M(-52.1%) | $1.40 B(-35.3%) |
Dec 2017 | $2.16 B(+98.1%) | $493.50 M(+10.2%) | $2.16 B(+1.3%) |
Sept 2017 | - | $447.70 M(+102.0%) | $2.13 B(+11.5%) |
June 2017 | - | $221.60 M(-77.9%) | $1.91 B(-1.2%) |
Mar 2017 | - | $1.00 B(+115.3%) | $1.94 B(+77.5%) |
Dec 2016 | $1.09 B(-32.8%) | $464.80 M(+104.3%) | $1.09 B(-7.6%) |
Sept 2016 | - | $227.50 M(-7.3%) | $1.18 B(-7.5%) |
June 2016 | - | $245.40 M(+59.0%) | $1.28 B(-8.2%) |
Mar 2016 | - | $154.30 M(-72.2%) | $1.39 B(-14.4%) |
Dec 2015 | $1.63 B(+3.9%) | $554.20 M(+71.3%) | $1.63 B(-11.6%) |
Sept 2015 | - | $323.50 M(-10.1%) | $1.84 B(-1.0%) |
June 2015 | - | $359.90 M(-7.4%) | $1.86 B(+6.0%) |
Mar 2015 | - | $388.60 M(-49.3%) | $1.75 B(+11.9%) |
Dec 2014 | $1.57 B(+43.2%) | $767.10 M(+124.4%) | $1.57 B(+16.5%) |
Sept 2014 | - | $341.90 M(+34.1%) | $1.34 B(+7.0%) |
June 2014 | - | $254.90 M(+26.2%) | $1.26 B(+10.4%) |
Mar 2014 | - | $202.00 M(-62.9%) | $1.14 B(+4.0%) |
Dec 2013 | $1.09 B(+4.7%) | $545.20 M(+114.8%) | $1.09 B(+9.5%) |
Sept 2013 | - | $253.80 M(+86.1%) | $998.10 M(+3.9%) |
June 2013 | - | $136.40 M(-13.6%) | $960.40 M(-7.5%) |
Mar 2013 | - | $157.90 M(-64.9%) | $1.04 B(-0.6%) |
Dec 2012 | $1.04 B(-38.3%) | $450.00 M(+108.2%) | $1.04 B(+19.0%) |
Sept 2012 | - | $216.10 M(+1.1%) | $877.30 M(-13.1%) |
June 2012 | - | $213.80 M(+30.1%) | $1.01 B(-24.5%) |
Mar 2012 | - | $164.30 M(-42.0%) | $1.34 B(-21.0%) |
Dec 2011 | $1.69 B(+42.7%) | $283.10 M(-18.8%) | $1.69 B(+0.5%) |
Sept 2011 | - | $348.60 M(-35.7%) | $1.68 B(+10.9%) |
June 2011 | - | $542.20 M(+4.5%) | $1.52 B(-0.8%) |
Mar 2011 | - | $519.00 M(+89.2%) | $1.53 B(+29.0%) |
Dec 2010 | $1.19 B(+38.8%) | $274.30 M(+49.8%) | $1.19 B(-5.8%) |
Sept 2010 | - | $183.10 M(-67.0%) | $1.26 B(+0.7%) |
June 2010 | - | $554.20 M(+216.5%) | $1.25 B(+43.2%) |
Mar 2010 | - | $175.10 M(-49.5%) | $873.10 M(+2.1%) |
Dec 2009 | $855.00 M(-20.0%) | $346.80 M(+99.0%) | $855.00 M(+9.1%) |
Sept 2009 | - | $174.30 M(-1.5%) | $783.90 M(-5.6%) |
June 2009 | - | $176.90 M(+12.7%) | $830.50 M(-13.0%) |
Mar 2009 | - | $157.00 M(-43.1%) | $955.00 M(-10.7%) |
Dec 2008 | $1.07 B(-1.2%) | $275.70 M(+24.8%) | $1.07 B(-7.8%) |
Sept 2008 | - | $220.90 M(-26.7%) | $1.16 B(-0.8%) |
June 2008 | - | $301.40 M(+11.1%) | $1.17 B(+5.0%) |
Mar 2008 | - | $271.20 M(-26.0%) | $1.11 B(+2.9%) |
Dec 2007 | $1.08 B | $366.70 M(+59.4%) | $1.08 B(-3.8%) |
Sept 2007 | - | $230.10 M(-6.5%) | $1.13 B(-3.9%) |
June 2007 | - | $246.20 M(+2.8%) | $1.17 B(+1.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $239.40 M(-41.6%) | $1.16 B(+7.3%) |
Dec 2006 | $1.08 B(-17.0%) | $410.00 M(+48.7%) | $1.08 B(-0.9%) |
Sept 2006 | - | $275.70 M(+19.1%) | $1.09 B(+1.6%) |
June 2006 | - | $231.40 M(+44.0%) | $1.07 B(-12.0%) |
Mar 2006 | - | $160.70 M(-61.7%) | $1.22 B(-6.3%) |
Dec 2005 | $1.30 B(-31.6%) | $419.60 M(+62.3%) | $1.30 B(-3.7%) |
Sept 2005 | - | $258.60 M(-31.5%) | $1.35 B(-12.8%) |
June 2005 | - | $377.70 M(+55.9%) | $1.55 B(-7.8%) |
Mar 2005 | - | $242.20 M(-48.5%) | $1.68 B(-11.7%) |
Dec 2004 | $1.90 B(+11.2%) | $470.00 M(+3.0%) | $1.90 B(-9.0%) |
Sept 2004 | - | $456.40 M(-10.2%) | $2.09 B(+3.7%) |
June 2004 | - | $508.10 M(+9.6%) | $2.01 B(+6.4%) |
Mar 2004 | - | $463.60 M(-29.5%) | $1.89 B(+10.8%) |
Dec 2003 | $1.71 B(+50.9%) | $657.80 M(+72.0%) | $1.71 B(+18.5%) |
Sept 2003 | - | $382.40 M(-1.4%) | $1.44 B(+4.5%) |
June 2003 | - | $387.80 M(+39.2%) | $1.38 B(+13.2%) |
Mar 2003 | - | $278.60 M(-28.7%) | $1.22 B(+7.6%) |
Dec 2002 | $1.13 B(+27.9%) | $390.90 M(+22.1%) | $1.13 B(+7.4%) |
Sept 2002 | - | $320.20 M(+41.0%) | $1.05 B(+9.6%) |
June 2002 | - | $227.10 M(+17.9%) | $961.20 M(+4.2%) |
Mar 2002 | - | $192.70 M(-38.5%) | $922.70 M(+4.4%) |
Dec 2001 | $884.00 M(+30.4%) | $313.40 M(+37.5%) | $884.00 M(+8.4%) |
Sept 2001 | - | $228.00 M(+20.9%) | $815.50 M(+9.5%) |
June 2001 | - | $188.60 M(+22.5%) | $744.50 M(+3.1%) |
Mar 2001 | - | $154.00 M(-37.1%) | $721.90 M(+6.5%) |
Dec 2000 | $677.90 M(+28.3%) | $244.90 M(+56.0%) | $677.90 M(+5.7%) |
Sept 2000 | - | $157.00 M(-5.4%) | $641.10 M(+28.5%) |
June 2000 | - | $166.00 M(+50.9%) | $499.00 M(-9.9%) |
Mar 2000 | - | $110.00 M(-47.1%) | $553.60 M(+4.8%) |
Dec 1999 | $528.30 M(+25.8%) | $208.10 M(+1296.6%) | $528.30 M(+11.0%) |
Sept 1999 | - | $14.90 M(-93.2%) | $476.00 M(-7.1%) |
June 1999 | - | $220.60 M(+160.4%) | $512.40 M(+20.0%) |
Mar 1999 | - | $84.70 M(-45.6%) | $426.90 M(+1.7%) |
Dec 1998 | $419.90 M(+14.6%) | $155.80 M(+203.7%) | $419.90 M(+0.8%) |
Sept 1998 | - | $51.30 M(-62.0%) | $416.70 M(-6.0%) |
June 1998 | - | $135.10 M(+73.9%) | $443.10 M(+15.0%) |
Mar 1998 | - | $77.70 M(-49.1%) | $385.30 M(+5.2%) |
Dec 1997 | $366.30 M(-17.5%) | $152.60 M(+96.4%) | $366.30 M(+23.5%) |
Sept 1997 | - | $77.70 M(+0.5%) | $296.70 M(-14.5%) |
June 1997 | - | $77.30 M(+31.7%) | $347.10 M(-13.5%) |
Mar 1997 | - | $58.70 M(-29.3%) | $401.50 M(-9.6%) |
Dec 1996 | $443.90 M(-19.5%) | $83.00 M(-35.2%) | $443.90 M(-14.5%) |
Sept 1996 | - | $128.10 M(-2.7%) | $519.10 M(-3.6%) |
June 1996 | - | $131.70 M(+30.3%) | $538.40 M(-3.1%) |
Mar 1996 | - | $101.10 M(-36.1%) | $555.50 M(+0.8%) |
Dec 1995 | $551.30 M(-4.4%) | $158.20 M(+7.3%) | $551.30 M(-11.3%) |
Sept 1995 | - | $147.40 M(-0.9%) | $621.20 M(+8.8%) |
June 1995 | - | $148.80 M(+53.6%) | $571.10 M(+1.7%) |
Mar 1995 | - | $96.90 M(-57.5%) | $561.50 M(-2.6%) |
Dec 1994 | $576.50 M(-9.0%) | $228.10 M(+134.4%) | $576.50 M(+2.8%) |
Sept 1994 | - | $97.30 M(-30.1%) | $560.80 M(-6.6%) |
June 1994 | - | $139.20 M(+24.4%) | $600.60 M(-1.1%) |
Mar 1994 | - | $111.90 M(-47.3%) | $607.40 M(-4.1%) |
Dec 1993 | $633.50 M(-36.8%) | $212.40 M(+54.9%) | $633.50 M(-21.8%) |
Sept 1993 | - | $137.10 M(-6.1%) | $810.40 M(+2.0%) |
June 1993 | - | $146.00 M(+5.8%) | $794.20 M(-15.8%) |
Mar 1993 | - | $138.00 M(-64.6%) | $943.00 M(-5.9%) |
Dec 1992 | $1.00 B(-12.3%) | $389.30 M(+222.0%) | $1.00 B(+5.9%) |
Sept 1992 | - | $120.90 M(-59.0%) | $946.40 M(-14.8%) |
June 1992 | - | $294.80 M(+49.6%) | $1.11 B(+1.4%) |
Mar 1992 | - | $197.10 M(-40.9%) | $1.09 B(-4.2%) |
Dec 1991 | $1.14 B(+13.4%) | $333.60 M(+17.0%) | $1.14 B(-6.4%) |
Sept 1991 | - | $285.20 M(+2.2%) | $1.22 B(+4.7%) |
June 1991 | - | $279.00 M(+14.1%) | $1.16 B(+7.0%) |
Mar 1991 | - | $244.60 M(-40.5%) | $1.09 B(+8.1%) |
Dec 1990 | $1.01 B(+81.7%) | $411.30 M(+78.9%) | $1.01 B(+69.0%) |
Sept 1990 | - | $229.90 M(+13.2%) | $596.00 M(+62.8%) |
June 1990 | - | $203.10 M(+24.6%) | $366.10 M(+124.6%) |
Mar 1990 | - | $163.00 M | $163.00 M |
Dec 1989 | $554.50 M | - | - |
FAQ
- What is Eli Lilly and Company annual capital expenditures?
- What is the all time high annual CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company annual CAPEX year-on-year change?
- What is Eli Lilly and Company quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly CAPEX year-on-year change?
- What is Eli Lilly and Company TTM capital expenditures?
- What is the all time high TTM CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company TTM CAPEX year-on-year change?
What is Eli Lilly and Company annual capital expenditures?
The current annual CAPEX of LLY is $7.39 B
What is the all time high annual CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high annual capital expenditures is $7.39 B
What is Eli Lilly and Company annual CAPEX year-on-year change?
Over the past year, LLY annual capital expenditures has changed by +$4.41 B (+147.62%)
What is Eli Lilly and Company quarterly capital expenditures?
The current quarterly CAPEX of LLY is $4.17 B
What is the all time high quarterly CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly capital expenditures is $4.17 B
What is Eli Lilly and Company quarterly CAPEX year-on-year change?
Over the past year, LLY quarterly capital expenditures has changed by +$169.60 M (+4.24%)
What is Eli Lilly and Company TTM capital expenditures?
The current TTM CAPEX of LLY is $8.31 B
What is the all time high TTM CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM capital expenditures is $8.31 B
What is Eli Lilly and Company TTM CAPEX year-on-year change?
Over the past year, LLY TTM capital expenditures has changed by +$1.93 B (+30.22%)